SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-20-020913
Filing Date
2020-08-07
Accepted
2020-08-07 16:33:42
Documents
6
Period of Report
2020-09-16
Effectiveness Date
2020-08-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea124907-def14a_soligenix.htm DEF 14A 392713
2 GRAPHIC img_001.jpg GRAPHIC 5093
3 GRAPHIC img_002.jpg GRAPHIC 938
4 GRAPHIC img_003.jpg GRAPHIC 914
5 GRAPHIC proxy_001.jpg GRAPHIC 443461
6 GRAPHIC proxy_002.jpg GRAPHIC 427960
  Complete submission text file 0001213900-20-020913.txt   1603984
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14778 | Film No.: 201085410
SIC: 2834 Pharmaceutical Preparations